159 related articles for article (PubMed ID: 32062006)
1. Nonadherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky.
Chow Z; Gan T; Chen Q; Huang B; Schoenberg N; Dignan M; Evers BM; Bhakta AS
J Am Coll Surg; 2020 Apr; 230(4):428-439. PubMed ID: 32062006
[TBL] [Abstract][Full Text] [Related]
2. Locally Advanced Colon Cancer: Evaluation of Current Clinical Practice and Treatment Outcomes at the Population Level.
Klaver CE; Gietelink L; Bemelman WA; Wouters MW; Wiggers T; Tollenaar RA; Tanis PJ;
J Natl Compr Canc Netw; 2017 Feb; 15(2):181-190. PubMed ID: 28188188
[No Abstract] [Full Text] [Related]
3. Racial/ethnic disparities in the adjuvant chemotherapy of locally advanced colon cancer patients.
Zhong X; Guo Z; Gao P; Song Y; Sun J; Chen X; Sun Y; Wang Z
J Surg Res; 2018 Aug; 228():27-34. PubMed ID: 29907221
[TBL] [Abstract][Full Text] [Related]
4. Adherence to stage-specific treatment guidelines for patients with colon cancer.
Chagpar R; Xing Y; Chiang YJ; Feig BW; Chang GJ; You YN; Cormier JN
J Clin Oncol; 2012 Mar; 30(9):972-9. PubMed ID: 22355049
[TBL] [Abstract][Full Text] [Related]
5. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
Kim RH; Kavanaugh MM; Caldito GC
Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
[TBL] [Abstract][Full Text] [Related]
7. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer.
Boland GM; Chang GJ; Haynes AB; Chiang YJ; Chagpar R; Xing Y; Hu CY; Feig BW; You YN; Cormier JN
Cancer; 2013 Apr; 119(8):1593-601. PubMed ID: 23280510
[TBL] [Abstract][Full Text] [Related]
8. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
9. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
10. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
[TBL] [Abstract][Full Text] [Related]
11. Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.
O'Grady MA; Slater E; Sigurdson ER; Meropol NJ; Weinstein A; Lusch CJ; Sein E; Keeley P; Miller B; Engstrom PF; Cohen SJ
Clin Colorectal Cancer; 2011 Jun; 10(2):113-6. PubMed ID: 21859563
[TBL] [Abstract][Full Text] [Related]
12. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
[TBL] [Abstract][Full Text] [Related]
13. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
14. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
[TBL] [Abstract][Full Text] [Related]
17. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials.
Batra A; Kong S; Cheung WY
Clin Colorectal Cancer; 2020 Dec; 19(4):e226-e234. PubMed ID: 32636076
[TBL] [Abstract][Full Text] [Related]
18. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
19. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]